Search Orphan Drug Designations and Approvals
-
| Generic Name: | Alefacept |
|---|---|
| Date Designated: | 12/19/2007 |
| Orphan Designation: | For use as prophylaxis of rejection in patients receiving allogenic solid organ transplants. |
| Orphan Designation Status: | Designated/Withdrawn |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Astellas Pharma Global Development, Inc. 1 Astellas Way Northbrook, Illinois 60062 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
-
